Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptive Biotechnologies Corp

7.78
-0.0400-0.51%
Volume:37.94K
Turnover:294.99K
Market Cap:1.16B
PE:-7.18
High:7.83
Open:7.78
Low:7.72
Close:7.82
Loading ...

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

GlobeNewswire
·
11 Apr

Adaptive Biotechnologies' Mantle Cell Lymphoma Test Receives Expanded Medicare Coverage

MT Newswires Live
·
08 Apr

Adaptive Biotechnologies Receives Expanded Medicare Coverage of Clonoseq® for Surveillance in Mantle Cell Lymphoma

THOMSON REUTERS
·
08 Apr

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)

TIPRANKS
·
31 Mar

Adaptive Biotechnologies Gains Following Goldman Sachs Upgrade, Share Climb 6% Near Friday Close

MT Newswires Live
·
22 Mar

Adaptive Biotechnologies Raised to Buy From Neutral by Goldman Sachs

Dow Jones
·
21 Mar

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8

MT Newswires Live
·
21 Mar

Adaptive Biotechnologies (ADPT) Gets a Buy from BTIG

TIPRANKS
·
18 Mar

Adaptive Biotechnologies launches assay enhancements for clonoSeq

TIPRANKS
·
11 Mar

Catherine Wood's Strategic Reduction in Adaptive Biotechnologies Corp Shares

GuruFocus
·
15 Feb

Adaptive Biotechnologies Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
14 Feb

Stock Track | Adaptive Biotechnologies Soars 5% in Pre-Market as Full Year Earnings Beat Expectations

Stock Track
·
13 Feb

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank

TIPRANKS
·
13 Feb

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
13 Feb

Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade

Zacks
·
13 Feb

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

Thomson Reuters StreetEvents
·
12 Feb

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

Zacks
·
12 Feb

U.S. RESEARCH ROUNDUP-Edison International, Onestream, Vertex Pharmaceuticals

Reuters
·
12 Feb

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...

GuruFocus.com
·
12 Feb

Adaptive Biotechnologies Corp : JP Morgan Raises Target Price to $9 From $8

THOMSON REUTERS
·
12 Feb